Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
Today Canada becomes the first major economy to legalize recreational marijuana.
But you don't need me to tell you that.
Turn on your television or radio. Check out the front-page headlines. Or just follow your social media feed.
But don't follow them too closely.
Because they're not telling you the full story.
You see, a lot of naysayers are going to try to rain on today's parade.
They're going to tell you that not enough stores have opened. (So what?! Have these folks never heard of online shopping?)
They'll tell you there's already a supply glut.
They'll tell you to "sell the news" – as if you've never heard that one before.
All that negative talk is just noise. And the No. 1 rule in Your Tech Blueprint is to "Separate the Signals from the Noise."
And there are a lot of signals out there. Profitable signals.
Critical Update: You’re Invited to the First-Ever National Event for Cannabis Investors on October 23rd – Click Here to Register for This Free Online Event
I'm talking about the $22.6 billion that Canada's cannabis market is expected to generate in the next few years.
I'm talking about the 10.5 million square foot hydroponic greenhouse in western Canada that soon will be able to grow $600 million worth of marijuana.
I'm talking about the $100 billion worldwide market for medical marijuana – marijuana that Canada can now export.
Those are very real signals.
Which means there is money to be made in this brand-new, completely untouched industry.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.
